Cargando…
Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant
Nucleoside analogs/derivatives (NAs/NDs) with potent antiviral activities are now deemed very convenient choices for the treatment of coronavirus disease 2019 (COVID-19) arisen by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. At the same time, the appearance of a new st...
Autores principales: | Abdalla, Mohnad, Rabie, Amgad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450471/ https://www.ncbi.nlm.nih.gov/pubmed/36842392 http://dx.doi.org/10.1016/j.compbiolchem.2022.107768 |
Ejemplares similares
-
Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study
por: Rabie, Amgad M., et al.
Publicado: (2022) -
Promising Experimental
Anti-SARS-CoV-2 Agent
“SLL-0197800”: The Prospective Universal Inhibitory
Properties against the Coming Versions of the Coronavirus
por: Rabie, Amgad M., et al.
Publicado: (2023) -
Novel Investigational
Anti-SARS-CoV-2 Agent
Ensitrelvir “S-217622”: A Very Promising Potential Universal
Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus
Species
por: Eltayb, Wafa A., et al.
Publicado: (2023) -
Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising In-Silico/In-Vitro Repurposing Research Study against the COVID-19 Omicron Virus (B.1.1.529.3 Lineage)
por: Rabie, Amgad M., et al.
Publicado: (2023) -
Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study
por: Rabie, Amgad M., et al.
Publicado: (2023)